Outsourced Pharma App Notes & Case Studies

  1. Case Study: ThioBridge™ Conjugates 4/14/2025

    Discover how Abzena’s ThioBridge™ technology is enabling the next generation of stable, scalable, and clinically advanced ADCs through site-specific conjugation.

  2. Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives 7/17/2024

    A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.

  3. CDMO Accelerates Contract Manufacturing With Electronic Batch Records 9/18/2024

    A prominent CDMO sought a specialized software solution to streamline and accelerate its manufacturing processes, enabling the efficient production of complex, customized products in record time.

  4. Novel Engineered Plasmids, Optimized HEK293 Cell Line For AAV Productivity 3/5/2024

    Lonza has further improved its platform process with the creation of engineered plasmids that afford significantly higher titers and productivity levels compared to standard systems.

  5. Meet Singota's 'Dr. Impossible' 2/26/2025

    Explore how Dr. Shehaab Savliwala, a leading formulation scientist at Singota Solutions, transforms complex pharmaceutical challenges into breakthroughs, leveraging expertise in nanoparticle formulations and innovative drug delivery

  6. Focus On Your Core Business Strategy 7/10/2025

    Eurofins PSS helped a Southeast U.S. manufacturer outsource lab functions by transitioning key staff, reducing costs, and fully managing a compliant GMP QC lab program.

  7. Impact Of Glycosylation On The Effector Functions Of Monoclonal Antibodies 2/9/2024

    In an example using rituximab and its biosimilars, explore the significance of minor differences of glycosylation in antibodies and its impact on their properties and functionality.

  8. Advancements In GLP-1 Analog Formulation: Overcoming Challenges 2/3/2025

    Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.

  9. Re-Engineering A Complex Process For FDA Compliance 8/21/2024

    Discover the strategies that helped a company navigate a complex and shifting regulatory landscape to rapidly re-engineer a COVID-19 vaccine manufacturing process for FDA compliance.

  10. Use Of Reconstructed Tissue And 3D Printed CT-Based Nasal Casts 7/3/2025

    Reconstructed nasal epithelium and CT-based 3D nasal casts provide more predictive, physiologically relevant models for assessing nasal drug delivery, improving accuracy in formulation development.